Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.

Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J.

Clin Transplant. 2010 Sep-Oct;24(5):701-8. doi: 10.1111/j.1399-0012.2009.01169.x.

PMID:
20047619
2.
3.

Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.

Alkhouri N, Hanouneh IA, Lopez R, Zein NN.

Liver Transpl. 2010 Feb;16(2):155-62. doi: 10.1002/lt.21939.

4.

Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.

Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A.

Clin Transplant. 2006 Sep-Oct;20(5):624-33.

PMID:
16968489
5.

Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.

Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR.

Liver Transpl. 2002 Sep;8(9):814-21.

6.

Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.

Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER.

J Heart Lung Transplant. 2008 Sep;27(9):990-4. doi: 10.1016/j.healun.2008.06.005.

PMID:
18765191
7.

c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.

Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL.

Transplant Proc. 2006 Dec;38(10):3597-600.

PMID:
17175342
8.

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.

Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA.

Liver Transpl Surg. 1997 Jul;3(4):398-406.

9.

Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients.

Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, Machicao V, Levy C, Nelson D, Morelli G.

Liver Transpl. 2009 Feb;15(2):216-22. doi: 10.1002/lt.21666.

10.

The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.

Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK.

Liver Transpl. 2001 May;7(5):436-41.

11.

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.

Schirren CA, Jung MC, Worzfeld T, Mamin M, Baretton G, Gerlach JT, Gruener NH, Zachoval R, Houghton M, Rau HG, Pape GR.

J Infect Dis. 2001 Apr 15;183(8):1187-94. Epub 2001 Mar 14.

PMID:
11262200
12.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061
13.

ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?

Schmeding M, Kienlein S, Röcken C, Neuhaus R, Neuhaus P, Heidenhain C, Neumann UP.

Transpl Immunol. 2010 Aug;23(4):156-60. doi: 10.1016/j.trim.2010.06.002. Epub 2010 Jun 14.

PMID:
20558292
14.

Evolution of hepatitis C virus in liver allografts.

Demetris AJ.

Liver Transpl. 2009 Nov;15 Suppl 2:S35-41. doi: 10.1002/lt.21890.

15.

Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.

MacQuillan GC, de Boer WB, Allan JE, Platten MA, Reed WD, Jeffrey GP.

Clin Transplant. 2010 Mar-Apr;24(2):252-8. doi: 10.1111/j.1399-0012.2009.01068.x. Epub 2009 Aug 27.

PMID:
19712085
16.

Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.

McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.

Liver Transpl. 2004 Aug;10(8):975-85.

17.

Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.

Asaoka T, Kato T, Marubashi S, Dono K, Hama N, Takahashi H, Kobayashi S, Takeda Y, Takemasa I, Nagano H, Yoshida H, Ruiz P, Tzakis AG, Matsubara K, Monden M, Doki Y, Mori M.

Liver Transpl. 2009 Dec;15(12):1738-49. doi: 10.1002/lt.21883.

18.

Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.

Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G.

Ther Drug Monit. 2012 Feb;34(1):4-10. doi: 10.1097/FTD.0b013e31823c5668.

PMID:
22210096
19.

Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.

Ciccorossi P, Filipponi F, Oliveri F, Campani D, Colombatto P, Bonino F, Campa M, Maltinti G, Mosca F, Brunetto MR.

J Viral Hepat. 2003 May;10(3):168-73.

PMID:
12753334
20.

Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.

Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.

Liver Transpl. 2000 Mar;6(2):222-8.

PMID:
10719024

Supplemental Content

Support Center